These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 15070911)
1. Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome. Cochran E; Young JR; Sebring N; DePaoli A; Oral EA; Gorden P J Clin Endocrinol Metab; 2004 Apr; 89(4):1548-54. PubMed ID: 15070911 [TBL] [Abstract][Full Text] [Related]
2. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy. Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130 [TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Javor ED; Cochran EK; Musso C; Young JR; Depaoli AM; Gorden P Diabetes; 2005 Jul; 54(7):1994-2002. PubMed ID: 15983199 [TBL] [Abstract][Full Text] [Related]
4. Leptin therapy for partial lipodystrophy linked to a PPAR-gamma mutation. Guettier JM; Park JY; Cochran EK; Poitou C; Basdevant A; Meier M; Clément K; Magré J; Gorden P Clin Endocrinol (Oxf); 2008 Apr; 68(4):547-554. PubMed ID: 18076675 [TBL] [Abstract][Full Text] [Related]
5. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients. Musso C; Cochran E; Javor E; Young J; Depaoli AM; Gorden P Metabolism; 2005 Feb; 54(2):255-63. PubMed ID: 15690321 [TBL] [Abstract][Full Text] [Related]
6. Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients. Paz-Filho G; Esposito K; Hurwitz B; Sharma A; Dong C; Andreev V; Delibasi T; Erol H; Ayala A; Wong ML; Licinio J Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1401-8. PubMed ID: 18854428 [TBL] [Abstract][Full Text] [Related]
7. Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective. Musso C; Cochran E; Moran SA; Skarulis MC; Oral EA; Taylor S; Gorden P Medicine (Baltimore); 2004 Jul; 83(4):209-222. PubMed ID: 15232309 [TBL] [Abstract][Full Text] [Related]
8. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Freemark M; Bursey D Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776 [TBL] [Abstract][Full Text] [Related]
9. Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy. Park JY; Chong AY; Cochran EK; Kleiner DE; Haller MJ; Schatz DA; Gorden P J Clin Endocrinol Metab; 2008 Jan; 93(1):26-31. PubMed ID: 17940115 [TBL] [Abstract][Full Text] [Related]
10. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy. Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic use of recombinant methionyl human leptin. Vatier C; Gautier JF; Vigouroux C Biochimie; 2012 Oct; 94(10):2116-25. PubMed ID: 22464954 [TBL] [Abstract][Full Text] [Related]